Table 1.
I. Neurologic abnormalities: chiasmal, retrochiasmal, optic nerve chiasm | |
I.1. Vertical step | Limited visual field loss that respects the vertical meridian and that includes at least two abnormal points at or outside 15° along the vertical meridian. |
I.2. Quadrant | Significant visual field loss throughout an entire quadrant that respects the vertical midline. Essentially all points must have a P < 5% value on the total deviation plot. |
I.3. Partial hemianopia | A visual field defect that respects the vertical meridian and that is greater than one quadrant but less than a complete vertical hemifield. |
I.4. Hemianopia | A visual field defect that respects the vertical meridian and that involves essentially all points in a vertical hemifield. |
I.5. Three quadrant | Significant visual field loss throughout three quadrants; essentially all points must have a P < 5% value on the total deviation plot. |
II. Optic nerve abnormalities | |
II.1. Nerve fiber bundle abnormalities | |
II.1.a. Temporal wedge | A small visual field defect that is temporal to the blind spot. |
II.1.b. Enlarged blind spot | A visual field abnormality in the nerve fiber bundle region that involves at least two points and is contiguous with the blind spot. |
II.1.c. Nasal step | Limited visual field loss adjacent to the nasal horizontal meridian with at least one abnormal point at or outside 15° on the meridian. Cannot include more than one significant point (on either plot) in the nerve fiber bundle region on the temporal side. |
II.1.d. Paracentral | A relatively small visual field abnormality in the nerve fiber bundle region that is generally not contiguous with the blind spot or the nasal meridian. In particular, it does not involve points outside 15° that are adjacent to the nasal meridian. |
II.1.e. Partial arcuate | Visual field loss in the nerve fiber bundle region that extends incompletely from the blind spot to the nasal meridian. The defect is generally contiguous with either the blind spot or the nasal meridian and must include at least one abnormal location in the temporal visual field. |
II.1.f. Arcuate | Significant visual field loss in the nerve fiber bundle region, extending across contiguous abnormal points from the blind spot to at least one point outside 15° adjacent to the nasal meridian. |
II.1.g. Altidudinal | Severe visual field loss throughout the entire superior or inferior hemifield that respects the horizontal midline, with most points in the hemifield having a P < 5% value on the total deviation plot and the entire horizontal midline demonstrating abnormality. |
II.2. Diffuse abnormalities | |
II.2.a. Multiple foci | Visual field loss that includes two or more clusters of abnormal points (P < 5%) located in different areas of the visual field that do not correspond to a particular abnormality pattern. The loss must be present in both the total and pattern deviation plots. |
II.2.b. Widespread | Diffuse visual field loss that includes all four quadrants. The Glaucoma Hemifield Test may show a general reduction of sensitivity or the MD must have a P level < 5%. The corrected pattern standard deviation must not have a P level < 5%. Most abnormal points on the total deviation plot are not abnormal on the pattern deviation plot. |
II.3. Central abnormalities | |
II.3.a. Centrocecal | Visual field loss that is in the macular region and contiguous with the blind spot. The foveal threshold must have a P < 5% value. The loss must be symmetrical above and below the midline. |
II.3.b. Central | Visual field loss that is predominantly in the macular region. The foveal threshold must have a P < 5% value, and the visual acuity must be impaired. Can be associated with a single hemifield and paired with another defect. |
II.4. Severe abnormalities | |
II.4.a. Total loss of vision | Severe widespread visual field loss (MD ≤−20.00 dB) with visual acuity not totally impaired. |
III. Artifactual abnormalities |
|
Abbreviation: MD, mean deviation.